Transcript - Chapter 9 of 10 - The Patents
1:30:18 - 1:39:07
- Interactive sourced transcript
ON SCREEN TITLE CARD:
The United States Governmentvs.Stanislaw Burzynski, MD, PhD and all past, present, and future cancer patients.
Most of us would assume, that with any story such as this, surely there’s another side to it.
Our story is no exception.After the National Cancer Institute intentionally violated all protocols of their ownAntineoplaston trials, and after all state and federal agencies had failed in their 14-yearcampaign to remove Burzynski from society
after all of the dust settled
a profound truthbegan to emerge.
NARRATOR (reading from highlighted sections of an internal NCI memo, 10/31/91):
It was October 4th, 1991, that America’s National Cancer Institute hosted their site visit toBurzynski’s clinic, and verified for themselves that “anti
-tumor activity was documented by
the use of Antineoplastons.”
NARRATOR (reading from highlighted sections of US Patent #6,037,376):
Seventeen days later, on October 21st, 1991, The United States of America as represented by"The Department of Health and Human Services", and "Dr. Dvorit Samid" filed a patent forAntineoplastons AS2-
1. They even had the audacity to include Burzynski as a reference. “The
invention described herein may be manufactured, used and licensed by or for the government,
for governmental purposes...”[
At the time, Burzynski had no idea this had happened, but did have his suspicions when theybegan to openly test Phenylacetate without him, and the National Cancer Institute knew it.
NARRATOR (reading from highlighted sections of internal leaked NCI memo 4/29/93):
In an April 1993 NCI memo, distributed to those involved with Burzynski, they state theirconcerns: Political issues are a real concern. Congressman Bedell is concerned we are takingthe Antineoplastons away from Burzynski. Burzynski has patents on Antineoplastons. Since